Please login to the form below

Not currently logged in
Email:
Password:

aspirin

This page shows the latest aspirin news and features for those working in and with pharma, biotech and healthcare.

AZ says Brilinta hits the mark in diabetic heart disease

AZ says Brilinta hits the mark in diabetic heart disease

The study showed that in diabetics with CAD and no prior history of heart attack or stroke, Brilinta given on top of aspirin therapy achieved a statistically-significant reduction in a ... Last year, the GLOBAL LEADERS study last year also showed that

Latest news

  • Xarelto no better than aspirin in secondary stroke study Xarelto no better than aspirin in secondary stroke study

    low-dose aspirin, which is commonly prescribed for this purpose, but failed to hit the mark at the interim stage. ... While bleeding rates were low overall, an increase in bleeding was observed in the rivaroxaban arm compared to the low dose aspirin arm,

  • Xarelto beats aspirin for recurrent blood clots Xarelto beats aspirin for recurrent blood clots

    A new phase III trial shows that Bayer and Janssen's novel oral anticoagulant (NOAC) Xarelto is more effective than aspirin at preventing recurrent blood clots, with no increase in bleeding ... It's already known that after an initial few months of

  • MHRA launches medicines side effects awareness drive MHRA launches medicines side effects awareness drive

    The MHRA credits such reports for action including no longer prescribing aspirin to children, which resulted in the virtual elimination of Reye's syndrome cases in many EU countries.

  • NICE backs expanded use of Brilique in final guidance NICE backs expanded use of Brilique in final guidance

    Currently delivered at a 90mg dose with aspirin for 12 months after a heart attack, the oral drug could now be taken twice daily with aspirin at a 60mg dose for ... The new Final Appraisal Determination comes on the back of the PEGASUS study, which

  • NICE backs use of AZ's Brilique as maintenance therapy NICE backs use of AZ's Brilique as maintenance therapy

    AstraZeneca's antiplatelet drug Brilique can be used alongside aspirin as a long-term maintenance therapy in patients who have had a heart attack, according to NICE. . ... The value of longer-term use in heart attack patients was revealed in the PEGASUS

More from news
Approximately 1 fully matching, plus 68 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Natasha Giordano joins PLx Pharma Natasha Giordano joins PLx Pharma

    We are confident Natasha will be a driving force for PLx as we transition from the development phase to the commercial launch of our lead product, PL2200 Aspirin.”. ... I look forward to building on the compelling clinical data and initial market

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics